[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337653-105":59,"doc-detail-337653-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","transforming-cancer-care-in-australia-the-dawn-of-particle-therapy","Transforming cancer care in Australia - The dawn of particle therapy","","Editorial outlines the Australian Bragg Centre for Proton Therapy and Research as a major step in cancer treatment, positioning particle therapy as a precise external-beam modality that uses protons, neutrons, or carbon ions to target tumors while reducing exposure to healthy tissue. It explains the clinical rationale behind the Bragg peak and highlights evidence and benefits in paediatric and rare cancers. The piece discusses national delays, limited reimbursement indications, predicted patient eligibility, financial and infrastructure barriers, and the ongoing push for expanding access, especially for First Nations communities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transforming-cancer-care-in-australia-the-dawn-of-particle-therapy/337653/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transforming-cancer-care-in-australia-the-dawn-of-particle-therapy/337653.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is particle therapy and how does proton therapy differ from photon therapy?","Question",{"text":112,"@type":113},"Particle therapy is external-beam radiation using ionising particles (including protons). Proton therapy uses the properties of protons and the Bragg peak to deposit maximum energy in the tumor, contrasting with traditional photon-based (x-ray) approaches that deliver energy beyond the target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is the Bragg peak considered important for cancer patients?",{"text":117,"@type":113},"The Bragg peak phenomenon enables protons to deliver most energy directly into the tumor with minimal exit dose. This precision helps spare surrounding healthy tissue, which is particularly valuable for paediatric cases and adults with rare cancers where long-term side effects matter.",{"name":119,"@type":110,"acceptedAnswer":120},"What barriers slow down adoption of proton therapy across Australia?",{"text":121,"@type":113},"Adoption faces limitations such as a restricted set of approved reimbursable indications for proton therapy, which narrows eligible patient numbers. The editorial also cites high facility establishment and operating costs, workforce training needs, and financial justification concerns for building facilities in every major state.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337653,1791362404,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","EDITORIAL  \nTransforming cancer care in Australia: The dawn of particle therapy  \nPeter Gorayski, BSc, BMBS, FRACGP, FRANZCR 1,2,3,4, & Frank Saran, MD, FRCR, FRANZCR 1,2,3,4 1Royal Adelaide Hospital, Adelaide, South Australia, Australia  \n2South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia 3Australian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia  \n4Allied Health and Human Performance Academic Unit, University of South Australia, Adelaide, South Australia, Australia  \nJ Med Radiat Sci 71 (2024) 3–5  \ndoi: 10.1002/jmrs.784  \nThe development of the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) heralds asignificant shift in Australian healthcare, marking the introduction of particle therapy as a cutting-edge treatment option for cancer patients. This transformation is celebrated in this special edition of the Journal of Medical Radiation Sciences, which showcases the Australian radiation oncology community’s united effort to adopt this ground-breaking treatment modality.  \nParticle therapy is a form of external beam radiation therapy that uses ionising particles, such as protons, neutrons or carbon ions, to target and destroy cancer cells with precision while minimising damage to surrounding healthy tissue. Proton therapy, leveraging the unique properties of protons, contrasts sharply with traditional photon-based (x-ray) radiation therapy. The ‘Bragg peak’phenomenon allows protons to deposit their maximum energy directly into the tumour with minimal exit dose, sparing surrounding healthy tissue. This precision is particularly beneficial in paediatric cases and adults with rare cancers, where reducing long-term side effects is crucial. The first patient treatment with proton therapy in 1954 at Berkeley, California, set the stage for decades of advancements, culminating in a substantial body of clinical evidence, underpinning its increasing utility in cancer care.1 Studies have demonstrated particle therapy’s role in reducing secondary neoplasms and improving cognitive outcomes in paediatric patients, among others, propelling the global expansion of particle therapy facilities, as noted by the Particle Therapy Co-Operative Group (PTCOG) .2,3  \nAustralia acknowledges its tardiness in proton therapy, yet the recognition of its importance is evident through national working groups such as the Royal Australian and New Zealand College of Radiologists (RANZCR), the Trans-Tasman Radiation Oncology Group (TROG), the  \nAustralian Society of Medical Imaging and Radiation Therapy (ASMIRT), and the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) . Australian expertise in particle therapy is undeniable, as reflected in the breadth of research articles in this special edition. These contributions cover a wide range of topics, signifying a deep understanding and proficiency in particle therapy across the country.  \nHowever, the pathway to integrating particle therapy into national healthcare is fraught with challenges. The Medical Services Advisory Committee (MSAC) has currently approved a very limited set of reimbursable indications for proton therapy, constraining its application compared to countries like the United States, the United Kingdom, Germany and Japan.4 With over 150,000 Australians diagnosed with cancer annually and about 38% receiving radiation therapy (despite an optimal utilisation target of 52%), just over 440 patients per year are predicted to qualify for proton therapy under the current reimbursement model.5,6 This figure includes a significant portion of paediatric, adolescent and young adult (AYA) cases, leaving only a small percentage of adult patients eligible for this treatment.  \nThe potential for expanding proton therapy indications exists, mirroring international standards and evidence for conditions such as head and neck cancers andre-irradiation scenarios. Yet, the likelihood of a significant broa","cbCaitVrhijPB9mL","https://ap.wps.com/l/cbCaitVrhijPB9mL","pdf",93961,"English","# Editorial\n## Rationale and clinical precision of particle therapy\n## Progress, evidence, and international context\n## Australian reimbursement and access challenges\n## Cost, infrastructure, and future directions","[{\"question\":\"What is particle therapy and how does proton therapy differ from photon therapy?\",\"answer\":\"Particle therapy is external-beam radiation using ionising particles (including protons). Proton therapy uses the properties of protons and the Bragg peak to deposit maximum energy in the tumor, contrasting with traditional photon-based (x-ray) approaches that deliver energy beyond the target.\"},{\"question\":\"Why is the Bragg peak considered important for cancer patients?\",\"answer\":\"The Bragg peak phenomenon enables protons to deliver most energy directly into the tumor with minimal exit dose. This precision helps spare surrounding healthy tissue, which is particularly valuable for paediatric cases and adults with rare cancers where long-term side effects matter.\"},{\"question\":\"What barriers slow down adoption of proton therapy across Australia?\",\"answer\":\"Adoption faces limitations such as a restricted set of approved reimbursable indications for proton therapy, which narrows eligible patient numbers. The editorial also cites high facility establishment and operating costs, workforce training needs, and financial justification concerns for building facilities in every major state.\"}]","Transforming cancer care in Australia - The dawn of particle therapy | PDF",1790020005]